Physician profile
Michael Knott
NPI 1316151715
$2,108.75
in general payments reported to CMS, 2019-2025
18 companies · $398 in 2025
The $398 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $304 · 2022: $667 · 2023: $431 · 2024: $309 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,138.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,109.39 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $272.09 | 2024-2025 | Airsupra, Breztri |
| Abbvie INC. | $179.80 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $116.13 | 2023 | Verquvo, Belsomra, Steglatro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.12 | 2022-2025 | Jardiance |
| Lilly USA, LLC | $57.23 | 2021-2024 | Jardiance, Zepbound |
| Paratek Pharmaceuticals, INC. | $43.74 | 2025 | Nuzyra |
| Exact Sciences Corporation | $37.32 | 2024-2025 | Cologuard Collection Kit |
| Seqirus USA INC | $31.93 | 2025 | Fluad, Flucelvax |
| Kowa Pharmaceuticals America, INC. | $27.60 | 2023 | Livalo |
| Genentech USA, INC. | $18.49 | 2021 | |
| Grifols USA, LLC | $18.20 | 2024 | Prolastin-C Liquid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.09 | 2021 | |
| Medtronic, INC. | $15.78 | 2022 | |
| Esperion Therapeutics, INC. | $15.68 | 2024 | Nexletol |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $15.54 | 2024 | Voquezna |
| Allergan, INC. | $15.31 | 2021 | |
| Sanofi Pasteur INC. | $13.31 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Knott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.